Key Points
- CVS EVP Prem Shah bought 23,855 shares at an average of $83.89, spending about $2.0 million. The purchase increased his holdings by 36.9% to 88,516 shares.
- CVS reported quarterly earnings of $2.09 per share, beating the $1.65 consensus estimate, while revenue of $108.4 billion also exceeded expectations and rose 5.4% year over year.
- The company’s quarterly dividend is $0.665 per share, equivalent to $2.66 annually and a yield of about 3.2%.
CVS Health Corporation (NYSE:CVS - Get Free Report) EVP Prem Shah bought 23,855 shares of the business's stock in a transaction on Friday, November 6th. The shares were bought at an average price of $83.89 per share, for a total transaction of $2,001,195.95. Following the completion of the acquisition, the executive vice president owned 88,516 shares of the company's stock, valued at approximately $7,425,607.24. This represents a 36.89% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available at the SEC website.
CVS Health Trading Up 3.0%
Shares of NYSE:CVS opened at $83.76 on Friday. The firm has a market cap of $107.12 billion, a price-to-earnings ratio of 9.75, a PEG ratio of 0.82 and a beta of 0.58. The company's fifty day simple moving average is $90.37 and its 200 day simple moving average is $88.89. CVS Health Corporation has a 12 month low of $69.51 and a 12 month high of $110.68. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.74.
CVS Health (NYSE:CVS - Get Free Report) last announced its earnings results on Wednesday, November 4th. The pharmacy operator reported $2.09 EPS for the quarter, beating the consensus estimate of $1.65 by $0.44. The business had revenue of $108.40 billion for the quarter, compared to analysts' expectations of $104.72 billion. CVS Health had a return on equity of 13.12% and a net margin of 1.18%. The firm's revenue was up 5.4% on a year-over-year basis. During the same period in the prior year, the business posted $1.60 earnings per share. As a group, research analysts forecast that CVS Health Corporation will post 8.26 EPS for the current fiscal year.
CVS Health Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Monday, November 2nd. Investors of record on Thursday, October 22nd were given a dividend of $0.6650 per share. This represents a $2.66 annualized dividend and a yield of 3.2%. The ex-dividend date of this dividend was Thursday, October 22nd. CVS Health's dividend payout ratio is currently 30.97%.
Trending Headlines about CVS Health
Here are the key news stories impacting CVS Health this week:
- Positive Sentiment: Executive Vice President Prem Shah bought 23,855 shares for about $2 million, increasing his direct stake by 36.9%. The sizable purchase may signal confidence in CVS’s prospects. SEC filing
- Positive Sentiment: CVS beat third-quarter earnings and revenue estimates and raised its 2026 outlook, with Aetna’s recovery among the factors supporting the improved outlook. Q3 earnings call coverage
- Neutral Sentiment: UBS lowered its price target to $107 but maintained a Buy rating, indicating continued optimism while reflecting a more cautious valuation. UBS rating
- Negative Sentiment: The planned separation of the retail pharmacy business from the insurance and pharmacy-benefit operations by 2028 has raised questions about execution, costs, and the value of the two businesses. The announcement overshadowed the earnings beat and was followed by a sharp selloff. Breakup and stock reaction
- Negative Sentiment: Additional concerns include weaker Medicare ratings and AM Best placing ratings for Aetna subsidiaries under review, creating uncertainty around the insurance business. Medicare ratings coverage
Wall Street Analyst Weigh In
A number of research firms recently weighed in on CVS. Robert W. Baird set a $107.00 price target on shares of CVS Health in a report on Thursday, August 6th. Raymond James Financial set a $103.00 price target on shares of CVS Health in a research note on Friday. Sanford C. Bernstein reiterated an "outperform" rating and set a $112.00 price objective on shares of CVS Health in a research note on Wednesday, September 9th. Barclays dropped their target price on CVS Health from $108.00 to $107.00 and set an "overweight" rating for the company in a research report on Thursday. Finally, BMO Capital Markets set a $112.00 price target on shares of CVS Health in a report on Wednesday, September 9th. Twenty-two equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, CVS Health currently has a consensus rating of "Moderate Buy" and an average target price of $108.25.
View Our Latest Research Report on CVS Health
Institutional Investors Weigh In On CVS Health
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Kilter Group LLC bought a new position in CVS Health in the 2nd quarter valued at $27,000. J.Safra Asset Management Corp bought a new position in CVS Health in the 2nd quarter valued at approximately $30,000. Beaird Harris Wealth Management LLC increased its position in CVS Health by 201.0% in the second quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator's stock worth $30,000 after purchasing an additional 195 shares during the last quarter. Timbuktu Capital Management LLC bought a new stake in shares of CVS Health in the 2nd quarter valued at about $31,000. Finally, Dunhill Financial LLC acquired a new position in CVS Health during the second quarter worth $32,000. Hedge funds and other institutional investors own 80.66% of the company's stock.
About CVS Health
(
Get Free Report)
CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division.
The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.
Founded in 1963 as Consumer Value Stores in Lowell, Massachusetts, the company expanded from a retail pharmacy business into a broad health care organization and adopted the CVS Health name in 2014.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
